MAM
PFE icon

MMA Asset Management’s Pfizer PFE Stock Holding History

MMA Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$377K Buy
15,667
+875
+6% +$22.9K 0.12% 147
2026
Q1 		$415K Buy
14,792
+267
+2% +$7.11K 0.15% 127
2025
Q4 		$362K Buy
14,525
+324
+2% +$8.17K 0.13% 135
2025
Q3 		$362K Sell
14,201
-12,556
-47% -$310K 0.12% 139
2025
Q2 		$649K Buy
26,757
+5,744
+27% +$134K 0.25% 79
2025
Q1 		$532K Hold
21,013
– – 0.22% 72
2024
Q4 		$557K Sell
21,013
-11,110
-35% -$301K 0.24% 65
2024
Q3 		$973K Buy
32,123
+15,037
+88% +$439K 0.26% 62
2024
Q2 		$478K Sell
17,086
-560
-3% -$15.4K 0.22% 67
2024
Q1 		$499K Buy
17,646
+7,409
+72% +$206K 0.23% 70
2023
Q4 		$295K Sell
10,237
-101
-1% -$3.05K 0.16% 92
2023
Q3 		$343K Sell
10,338
-327
-3% -$11.6K 0.2% 80
2023
Q2 		$391K Buy
+10,665
New +$415K 0.23% 74
2021
Q2 		– Sell
-6,290
Closed -$228K – 105
2021
Q1 		$228K Sell
6,290
-1,383
-18% -$49.1K 0.2% 75
2020
Q4 		$282K Buy
+7,673
New +$281K 0.27% 64

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MMA Asset Management's PFE Position: Q2 2026 in Review

MMA Asset Management increased its Pfizer (PFE) stake by 5.9% in Q2 2026, buying an estimated $22.9K and bringing the position to 15,667 shares worth $377K. The position accounts for 0.12% of the portfolio, ranked #147.

MMA Asset Management first reported a position in PFE in Q4 2020 and has held it in 15 quarters since. The position peaked at $973K in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MMA Asset Management held 15,667 shares of Pfizer worth $377K as of Q2 2026.
  • MMA Asset Management bought 875 Pfizer shares in Q2 2026, an estimated $22.9K.
  • Pfizer made up 0.12% of MMA Asset Management's portfolio in Q2 2026, its #147 holding.
  • MMA Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 15 quarters since.
  • MMA Asset Management's Pfizer position peaked at $973K in Q3 2024.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MMA Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.